Novo's Denecimig gets CHMP nod for hemophilia A in the European Union
- Posted on September 18, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Novo's Denecimig gets CHMP nod for hemophilia A in the European Union
Novo NVO announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending the approval of denecimig (Mim8) for the treatment of hemophilia A, with or without inhibitors, in adults and children. Denecimig is a next-generation factor VIIIa (FVIIIa) mimetic bispecific antibody designed to prevent or reduce bleeding episodes through routine prophylactic treatment....
